Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.55
0.010.65%
Last update: Oct 20, 10:15 AM
$1.53
-0.0099-0.64%
NervGen Pharma Corp (NGEN) Stock Price, Quote, News & History
NGENNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NervGen Pharma (NASDAQ:NGEN) through any online brokerage.
Other companies in NervGen Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
NervGen Pharma has a consensus price target of $12.50.
The stock price for NervGen Pharma (NASDAQ: NGEN) is $1.55 last updated October 20, 2026 at 10:15 AM EDT.
There are no upcoming dividends for NervGen Pharma.
NervGen Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for NervGen Pharma.
NervGen Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
